Clinical trials
Acne Vulgaris clinical trials
Below are recruiting acne vulgaris clinical trials, each written for real people, not researchers. We’re tracking 14 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06403501RecruitingPhase 3
Clascoterone cream for facial acne
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
ShanghaiAges 12 years+ - NCT07007078RecruitingEarly Phase 1
Dihydroartemisinin for acne vulgaris
This study tests if a medicine called dihydroartemisinin (a type of artemisinin, often used for malaria) can help treat acne when applied to the skin. It's a small early-phase trial for people with acne vulgaris.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT07102186RecruitingPhase 4
Adapalene plus hyaluronic acid gel for mild to moderate acne
This trial compares a gel containing adapalene (a retinoid) plus hyaluronic acid (a moisturizer) to adapalene gel alone for mild to moderate acne. It aims to see if adding hyaluronic acid helps reduce irritation and improve results.
Cairo, Cairo GovernorateAges Any age - NCT07054398Recruiting
Catestatin levels in acne patients
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
AswānAges 18–40 - NCT07056673Recruiting
Cold plasma for moderate to severe acne
This study tests whether a treatment called 'cold atmospheric plasma' (similar to a gentle, cool gas) can improve moderate-to-severe acne. It might offer a new, drug-free option for people with many pimples or cysts.
Luoyang, HenanAges 18–40 - NCT06501560Recruiting
Acne genetics study in Indonesia
This study looks at genetic patterns in young people with acne in Indonesia. It aims to better understand why some people get acne, which may help improve future treatments.
Jakarta Pusat, Jakarta Special Capital RegionAges 17–60 - NCT07474883RecruitingEarly Phase 1
Timolol eye drops for red marks after acne
This trial tests if timolol eye drops, applied to the skin, can reduce red marks left by acne. It may be an option for people with acne-related redness who haven't responded to other treatments.
Ho Chi Minh CityAges 12 years+ - NCT06225570RecruitingEarly Phase 1
Weekly isotretinoin vs tetracycline for moderate acne
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
Charleston, South CarolinaAges 12 years+ - NCT07544251RecruitingPhase 4
Sarecycline vs. Doxycycline for Acne and Gut Health
This study compares two antibiotic medications (sarecycline and doxycycline) to see which one works better for moderate acne while also being gentler on the bacteria in your gut. Researchers will track how your skin improves and how these drugs affect your digestive system.
Sacramento, CaliforniaAges 9 years+ - NCT03883269RecruitingPhase 4
Tests topical antibiotics’ anti-inflammatory effect in acne
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
LeidenAges 18–45 - NCT06447480RecruitingPhase 3
Comparing isotretinoin to standard care for moderate acne in darker skin
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
Nice, Alpes-MaritimesAges 13–30 - NCT07296523Enrolling by invitation
Expert views on isotretinoin for acne
This study gathers opinions from experienced dermatologists to create expert guidelines on using isotretinoin for acne. It does not test a new treatment but aims to improve how isotretinoin is prescribed.
CairoAges Any age - NCT07524946RecruitingPhase 4
Safety and effectiveness of Cabtreo for moderate to severe acne
This study tests a new acne treatment called Cabtreo in children and young teens ages 9–11. The treatment combines three ingredients to reduce acne bumps and spots on the face and body.
Bryant, ArkansasAges 9–11 - NCT06655129Recruiting
Intense pulsed light for hair, acne, redness, or spots
This trial tests a light-based device (IPL) to treat unwanted hair, acne, redness (rosacea), or age spots. It may help if you are an adult with one of these skin concerns and have a lighter skin type (not very dark). The treatment is quick and gentle, with little downtime.
AuxerreAges 18 years+
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acne vulgaris?
- Yes. Clin2 currently lists 14 recruiting acne vulgaris studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acne vulgaris trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acne vulgaris trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.